tpi asm8

Nucleic acidexperimental

Clinical trial activity

4 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2007 (NCT00402948)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • tpi asm8

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01158898Phase 2Nov 1, 2010Laval University, McMaster University, Syntara, University of Calgary, Vancouver Coastal Health
NCT00822861Phase 2Apr 1, 2009Syntara, Topigen Pharmaceuticals Inc.
NCT00550797Phase 2Jan 1, 2008Optum, Syntara, Topigen Pharmaceuticals Inc., University of Amsterdam, University of London, University of Manchester, University of Padova, University of Pisa
NCT00402948Phase 2Feb 1, 2007Firestone Institute for Respiratory Health, Syntara
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SyntaraFor profit4412007
Topigen Pharmaceuticals Inc.For profit2012008
Firestone Institute for Respiratory HealthAcademic/Hospital1012007
Laval UniversityAcademic/Hospital1012010
McMaster UniversityAcademic/Hospital1012010
OptumFor profit1012008
University of AmsterdamAcademic/Hospital1012008
University of CalgaryAcademic/Hospital1012010
University of LondonAcademic/Hospital1012008
University of ManchesterAcademic/Hospital1012008
University of PadovaAcademic/Hospital1012008
University of PisaAcademic/Hospital1012008
Vancouver Coastal HealthAcademic/Hospital1012010
13 organizations
Page 1 / 1